Nature Communications (Sep 2023)

HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer

  • Emily N. Neubert,
  • Julia M. DeRogatis,
  • Sloan A. Lewis,
  • Karla M. Viramontes,
  • Pedro Ortega,
  • Monique L. Henriquez,
  • Rémi Buisson,
  • Ilhem Messaoudi,
  • Roberto Tinoco

DOI
https://doi.org/10.1038/s41467-023-41352-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Chronic infections and cancers evade the host immune system through mechanisms that induce T cell exhaustion. The heterogeneity within the exhausted CD8+ T cell pool has revealed the importance of stem-like progenitor (Tpex) and terminal (Tex) exhausted T cells, although the mechanisms underlying their development are not fully known. Here we report High Mobility Group Box 2 (HMGB2) protein expression is upregulated and sustained in exhausted CD8+ T cells, and HMGB2 expression is critical for their differentiation. Through epigenetic and transcriptional programming, we identify HMGB2 as a cell-intrinsic regulator of the differentiation and maintenance of Tpex cells during chronic viral infection and in tumors. Despite Hmgb2 −/− CD8+ T cells expressing TCF-1 and TOX, these master regulators were unable to sustain Tpex differentiation and long-term survival during persistent antigen. Furthermore, HMGB2 also had a cell-intrinsic function in the differentiation and function of memory CD8+ T cells after acute viral infection. Our findings show that HMGB2 is a key regulator of CD8+ T cells and may be an important molecular target for future T cell-based immunotherapies.